How to make more cancers vulnerable to immunotherapies

Cancer immunotherapies called checkpoint inhibitors can bring dramatic, life-saving results – but only for a limited fraction of patients. Aiming to help more patients benefit, researchers in...

Unlocking the combination to target evasive kidney cancers

Roughly one in four people with kidney cancer have a type that does not respond to targeted therapy drugs, leaving no proven treatment options for those whose tumors have started to...

First-in-class drug targets resistant ovarian cancer

Cancer researchers have discovered a way to target a pivotal driver of drug resistance in ovarian cancer, one of the top causes of cancer death in women. The experimental compound, called SU056,...

Beat AML study paves way for precision treatment

Using genetic information to match patients to targeted therapies may improve survival in people with a fast-moving leukemia. Because acute myeloid leukemia is such a fast-moving and deadly cancer,...

Three questions for radiation oncologist Ravi Chandra

Ravi Chandra, M.D., Ph.D., is an assistant professor of radiation medicine in the OHSU School of Medicine who has a special interest in serving as a bridge between scientists in the lab and the...

Lighting up nerves to prevent damage during surgery

Sparing nerves from injury remains a huge problem for surgeons. Researchers in Oregon have developed a possible solution: nerve-specific fluorescent dyes that allow operators to view nerves deeper...

Advancing immunotherapy for life-threatening prostate cancer

Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...